全文获取类型
收费全文 | 25793篇 |
免费 | 2652篇 |
国内免费 | 520篇 |
专业分类
耳鼻咽喉 | 135篇 |
儿科学 | 1030篇 |
妇产科学 | 785篇 |
基础医学 | 613篇 |
口腔科学 | 175篇 |
临床医学 | 1906篇 |
内科学 | 2275篇 |
皮肤病学 | 141篇 |
神经病学 | 191篇 |
特种医学 | 492篇 |
外国民族医学 | 64篇 |
外科学 | 2453篇 |
综合类 | 3186篇 |
现状与发展 | 2篇 |
预防医学 | 541篇 |
眼科学 | 100篇 |
药学 | 2156篇 |
17篇 | |
中国医学 | 801篇 |
肿瘤学 | 11902篇 |
出版年
2024年 | 57篇 |
2023年 | 315篇 |
2022年 | 731篇 |
2021年 | 1006篇 |
2020年 | 885篇 |
2019年 | 807篇 |
2018年 | 811篇 |
2017年 | 922篇 |
2016年 | 1154篇 |
2015年 | 1071篇 |
2014年 | 1572篇 |
2013年 | 2090篇 |
2012年 | 1440篇 |
2011年 | 1656篇 |
2010年 | 1257篇 |
2009年 | 1281篇 |
2008年 | 1256篇 |
2007年 | 1408篇 |
2006年 | 1276篇 |
2005年 | 1075篇 |
2004年 | 863篇 |
2003年 | 782篇 |
2002年 | 690篇 |
2001年 | 627篇 |
2000年 | 516篇 |
1999年 | 492篇 |
1998年 | 388篇 |
1997年 | 395篇 |
1996年 | 283篇 |
1995年 | 263篇 |
1994年 | 252篇 |
1993年 | 167篇 |
1992年 | 138篇 |
1991年 | 135篇 |
1990年 | 109篇 |
1989年 | 100篇 |
1988年 | 86篇 |
1987年 | 76篇 |
1986年 | 62篇 |
1985年 | 78篇 |
1984年 | 70篇 |
1983年 | 60篇 |
1982年 | 41篇 |
1981年 | 45篇 |
1980年 | 41篇 |
1979年 | 34篇 |
1978年 | 34篇 |
1977年 | 26篇 |
1976年 | 27篇 |
1975年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
15 patients with acute myeloid leukaemia (AML) were treated with low-dose cytosine arabinoside (LD ARA-C). 2 patients had complete remissions, which lasted for 8 and 3 months, and 5 patients had a partial remission. 46% of the patients thus responded to LD ARA-C. This included 1 responding patient who had not previously responded to therapy with 6-mercaptopurine, thioguanine, or vinblastine. The 2 patients with complete remission did not show LD ARA-C-induced hypoplasia of bone marrow, although 1 had hypoplastic AML before therapy. Leukaemic cells from 1 patient showed in vivo maturation from M1 to M3 after LD ARA-C treatment. The present results, together with the published data, indicate that: a. LD ARA-C treatment, although it may have some toxic effects, is an effective treatment for some patients with AML, especially those with hypoplastic AML; b. Response to LD ARA-C can be obtained after one or several courses of treatment; c. LD ARA-C-induced remissions are sometimes obtained even in patients who fail in more conventional treatments; d. LD ARA-C-induced remissions can be achieved without bone marrow hypoplasia, and induction of hypoplasia by itself does not always result in complete remission; e. LD ARA-C can induce in vivo maturation of leukaemic cells. It is suggested that induction of remission in AML patients by LD ARA-C may result from either differentiation of leukaemic blast cells, cytotoxicity to leukaemic blasts, or both mechanisms acting together. 相似文献
72.
Karl Lehner M.D. Maximilian Reiser Ulrich Gebhardt Andreas Heuck Jürgen Schaff 《Cardiovascular and interventional radiology》1987,10(2):71-74
In contrast to conventional film angiography, the perfusion pattern of hepatic arterial chemotherapy was consistently visualized
by DSA in 40 patients with implanted Infusaid pump or Port-A devices. Incomplete perfusion of a liver region by the cytotoxic
agent was recognized by DSA as accurately as by nuclide scintigraphy. Furthermore, DSA appeared to be more sensitive in determining
aberrantly perfused extrahepatic regions; this was especially true when there was a nonligated right hepatic artery. Specific
details of vascular lesions and associated complicating events also could be satisfactorily analyzed by DSA only. 相似文献
73.
KAR NENG LAI JOSEPH W. C. LEUNG PAUL N. M. CHENG FERNAND MAC-MOUNE LAI 《Journal of gastroenterology and hepatology》1987,2(5):467-472
Dialytic ultrafiltration with haemofilter was performed in 16 patients with malignant ascites refractory to treatment with sodium restriction, diuretic and systemic chemotherapy. A continuous flow of ascitic fluid at a rate of 300–400 ml/min through a haemofilter was maintained by a blood pump. The protein-rich ascitic fluid was re-infused into the peritoneal cavity with sodium and water removed. An average of 5.2 1 of filtrate was removed over a mean interval of 3.5 h. Bleomycin (60 mg) was administered intraperitoneally following the procedure. Complete response was observed in six patients (37.25%) and partial response occurred in four (25%). The remaining patients showed no response. Complications of the dialytic ultrafiltration procedure and toxicity of intraperitoneal administration of bleomycin were minimal. The technique of dialytic ultrafiltration is simple, safe and cost-effective and could be used as an adjuvant therapy for intraperitoneal chemotherapy. 相似文献
74.
75.
Background : The present paper addressed the issue of whether pretreatment with intravenous (IV) chemotherapy affects response rate or survival in patients receiving hepatic artery chemotherapy (HAC). Methods : Case note reviews of 164 patients treated in a teaching hospital from June 1990 to July 1996 were carried out. Results : The response rate and carcino-embryonic antigen (CEA) fall in the two groups was almost identical. There was a nonsignificant survival advantage in the non-pretreatment group. Conclusions : Previous administration of IV chemotherapy did not affect the CEA response of patients receiving HAC. 相似文献
76.
目的 探索早期乳腺癌保留乳房治疗的新途径。方法 1995 - 1997年采用术前动脉插管化疗加乳腺区段切除治疗Ⅰ、Ⅱ期乳腺癌共 2 6例 ,并随访 5年以上。结果 2 6例中 1例术后 2年 4个月死于肺转移 ,另 1例术后 4年死于其他疾病。 1例术后 1年复发 ,行全乳房切除后至今无瘤生存 6年。本组 3年生存率 (OS) 96 .15 % ,3年无瘤生存率 (DFS) 92 .3% ;5年OS 88.4 6 % ,5年DFS 88.4 6 %。结论 术前动脉插管化疗能提高肿瘤区域的药物浓度 ,杀灭部分癌细胞 ,减少术后复发。该疗法对部分Ⅰ、Ⅱ期乳腺癌病例是可行的。 相似文献
77.
Eigo Otsuji Toshiharu Yamaguchi Nozomi Yamaguchi Kunihiko Koyama Jiro Imanishi Nobuki Yamaoka Toshio Takahashi 《Surgery today》1992,22(4):351-356
In a previous study, we used a murine monoclonal antibody, A7, against human colon carcinoma as a drug-carrier to treat colorectal cancer.1 In the present study, we found that MAb A7 also reacted immunohistochemically with 73% of human pancreatic carcinoma cell lines, with the A7 antigen mainly being detected on the cell surface. However, the A7 antigen was found in only 9% of the spent media of these human pancreatic carcinoma cell lines by ELISA. On the other hand, the positive incidence of CA19-9, POA, ferritin, CEA, DU-PAN-2 and SLX in those spent media was 100%, 64%, 64%, 55%, 55% and 36%, respectively. These results suggest that the A7 antigen may only rarely be shed into the sera of pancreatic cancer patients, in which case MAb A7 could be a suitable drug-carrier in targeting chemotherapy for pancreatic cancer patients. 相似文献
78.
阿苯达唑脂质体治疗包虫病的初期临床观察 总被引:3,自引:0,他引:3
目的:评价阿苯达唑脂质体(L-ABZ)口服液的临床疗效及药物副作用,为该药的临床应用提供依据。方法:选择53例包虫病患者,分为3组:A组为单纯服药组(35例),连续口服L-ABZ 3-6个月;B组为包虫囊肿穿刺前后服药组(4例),穿刺前3-7d开始服药,穿刺后连服1个月;C组为手术前后服药组(14例),术前3-7d开始服药,术后可进食水后即开始服药,疗程1个月。3个治疗组服药剂量均为每天10mg/kg,2次/d。同时动态随访病人服药前后的血常规、肝肾功、胸部X线片、B超或CT以及病人对药物的毒副反应。用治愈率、有效率、部分有效率和无效率来衡量A组的疗效。以复发率(观察至少1年)来判断B、C组的疗效。结果:A组治愈16例(45.7%),有效9例(25.7%),部分有效6例(17.1%),无效4例(11.4%),总有效率88.6%;B组、C组随访时间1-3年,尚无复发。临床药物治疗的53例服药病人中,尚未见因药物的副反应而终止治疗的病例。结论:阿苯达唑脂质体(L-ABZ)口服液对包虫病病人疗效较为肯定,毒副反应轻,患者能够长期服用,尤其适用于某些不宜施行手术治疗或复杂的包虫病例。 相似文献
79.
5-FU多聚缓释体植入技术治疗脑胶质瘤 总被引:2,自引:0,他引:2
目的观察5-氟尿嘧啶(5-FU)多聚缓释体植入胶质瘤内化疗的临床效果,探索化疗药物的新剂型和新途径。方法在60例胶质瘤病人在开颅术中或以立体定向方式植入5-FU多聚缓释体,5-FU含量100~150mg。随访5~24周,通过影像学检查,计算肿瘤平均径。比较手术前及各随访时间段肿瘤平均径的变化,并观察瘤周水肿情况。结果38例病人术后病情稳定。无化疗不良反应。肿瘤平均径在术后5、12和24周以上均有显著缩小。其中第12周随访病例肿瘤平均径缩小最显著。肿瘤周边水肿带在开颅手术的病人比较宽,而在立体定向手术病人无明显加重表现。结论低剂量5-FU瘤内缓释体植入术治疗脑胶质瘤安全有效,无明显不良反应。 相似文献
80.
O. Reerink N. H. Mulder† B. G. Szabo W. J. Sluiter† T. Wiggers‡ A. H. H. Bongaerts§ G. A. P. Hospers† 《Colorectal disease》2004,6(6):406-417
Abstract The treatment options for primary irresectable rectal cancers are discussed. Assessment of tumour stage is the first step for an appropriate choice of treatment. Following a diagnosis of rectal cancer, a vast array of diagnostic procedures is available to determine its stage, and thereby its best treatment options. From the many (new) diagnostic options the merits and drawbacks are discussed. If a diagnosis of irresectability is made, further treatment options should include radiotherapy in most cases, some aspects of timing and application, i.e. intra-operative treatment are discussed. Chemotherapy options are manifold, the results are discussed and some new options are explored. 相似文献